Press Release

Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room , Potentially Minimizing Radiation Exposure and Reducing Physical Strain for the Healthcare Providers Design Patent Complements Existing U.S. and European Design Patents as Feedback During Recent Meetings Continues to

Dr. Giora Weisz , a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker. The Webinar is Intended for All Stakeholders Interested in the

Panel of Proven Medical Device Entrepreneurs and Surgical Robotics Pioneers Will Share Their Personal Experiences of Taking Innovative New Technologies from Development to Commercialization Views on the Current and Future Endovascular Market will be Highlighted Webinar will be Held on Tuesday,

The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022 , at 1:00pm ET                     Dr. Ripal Gandhi , a Renowned Miami-Based Interventional Oncologist, Will Share His Personal Experiences Having

Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress HINGHAM, Mass. , Dec. 08, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to strengthen its intellectual property (IP) portfolio, while advancing and securing its global commercialization

Advanced Features of Remote Controller Specifically Developed to Deliver an Enhanced User Experience During Endovascular Procedures HINGHAM, Mass. , Nov. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), in a continuation of its efforts to create barriers and expand its global

Th e “ Access-Ability Live” by MBOT will build an online community of healthcare industry leaders who are interested in robotics to come together and share their opinion and experience F irst Webinar on November 16 th at 1:00   pm ET will Focus on the Evolving Endovascular Space   P rocedure s and

Corresponding Application Previously Granted in the U.S. as the Company Continues to Create Global Barriers to Entry for its Novel Technology HINGHAM, Mass. , Nov. 03, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to aggressively protect its global intellectual property

Growing SAB Roster Includes 11   KOLs from Across the U.S. , Europe , and Israel Expansion of KOL Presence and Global Centers of Excellence Continues to Accelerate the Progression of the LIBERTY ® Robotic System to Meet Future Regulatory and Commercialization Milestones HINGHAM, Mass. , Oct.